Archives

img-01

Japan PAL Update: Adverse Effect Reporting

Even though Japan’s new Pharmaceutical Affairs Law (PAL) came into effect on April 1, 2005, the Ministry of Health, Labor and Welfare (MHLW) is still continuing to develop and release new guidance documents. The implementation of the new PAL has revamped the... Read More

img-01

Japan: Draft of New IVD Requirements Published

Japan’s Ministry of Health, Labor and Welfare (MHLW) recently published in English, a draft regulation on the requirements for marketing authorization approval for in vitro diagnostics (IVD). The MHLW will evaluate the purpose of use, principle, structure, shape, category specifications, usage, etc.... Read More